Ketamin Abcur (Ketamine)

Ketamine acts as a non‑competitive antagonist at the NMDA receptor, blocking excitatory glutamate signaling in the central nervous system. This disruption produces dissociative anesthesia and analgesia. Additional interactions with opioid receptors and monoaminergic pathways contribute to its pain‑relieving and sympathomimetic effects.

The specific dose of Ketamin Abcur is determined by the prescribing clinician based on the patient’s age, weight, clinical condition, and the intended use (e.g., induction of anesthesia versus procedural sedation). Dosing guidelines are provided in professional formularies and should be individualized for each patient.

Safety data for ketamine in pregnancy and lactation are limited. Because potential risks to the fetus or infant cannot be excluded, the product is generally avoided unless the therapeutic benefit justifies the potential hazard. Clinicians should assess risks and discuss options with the patient.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Ketamin Abcur. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ketamine differs from agents such as propofol or volatile anesthetics by preserving airway reflexes and providing analgesia while producing dissociative anesthesia. It also has sympathomimetic effects that can maintain blood pressure, making it useful in trauma or shock patients. However, it may cause emergence phenomena that are less common with other agents.

Ketamin Abcur should be stored below 25 °C in its original packaging, protected from light and moisture. The container must remain sealed until use, and any unused portion should be discarded according to local regulations for injectable medicines.

Ketamin Abcur is supplied as a sterile injectable solution and is administered by a qualified healthcare professional either intravenously or intramuscularly. The route, rate of injection and total volume are selected by the prescriber according to the clinical situation and patient response.

Serious adverse events include respiratory depression, severe hypertension, and cardiac arrhythmias. These complications require immediate monitoring of airway, breathing and circulation, and prompt intervention if they occur. Patients with pre‑existing cardiovascular disease or compromised respiratory function need particular vigilance.

Ketamin Abcur should be avoided in patients with known hypersensitivity to ketamine or its excipients, uncontrolled hypertension, severe coronary artery disease, or a history of psychosis that could be exacerbated by dissociative effects. Caution is also advised in patients with elevated intracranial pressure or significant hepatic impairment.